AMS - 2021-IMen-Internal Medicine- Diabetes

$119.00

5 AMA PRA Category 1 Credits™
$119.00
StreamingINCLUDED

Topics and Objectives

Title: IMen-Internal Medicine- Diabetes: Prevention of Type 2 Diabetes/Treatment of Obesity; Treatment of Hyperglycemia in Type 2 Diabetes (Non-Insulin); Treatment of Hyperglycemia in Type 2 Diabetes (Insulin)

Faculty: Merri Lou Pendergrass, M.D., Ph.D.

Original Release Date: July 1, 2021  Expiration Date: July 1, 2024

TOPIC 1: Prevention of Type 2 Diabetes/Treatment of Obesity.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Recognize patients with pre-diabetes.
  2. Employ current Guidelines and recommendations regarding diabetes prevention.
  3. Describe properties of currently available medications for obesity, their adverse effect profile, and how to incorporate them as part of an effective obesity treatment program.

TOPIC 2: Treatment of Hyperglycemia in Type 2 Diabetes (Non-Insulin)

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Understand the glucose targets in T2DM.
  2. Employ the current ADA Guidelines for pharmacological therapy.
  3. Develop individualized therapeutic regimens to optimize glycemic control.

TOPIC 3: Treatment of Hyperglycemia in Type 2 Diabetes (Insulin)

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Recognize indications for the initiation of insulin replacement therapy for people with T2DM.
  2. Describe clinically relevant properties of the available insulins and insulin combinations.
  3. Individualize and advance insulin therapy to optimize glycemic control.


Total Cost: $

Title: IMen-Internal Medicine- Diabetes: Prevention of Type 2 Diabetes/Treatment of Obesity; Treatment of Hyperglycemia in Type 2 Diabetes (Non-Insulin); Treatment of Hyperglycemia in Type 2 Diabetes (Insulin)

Faculty: Merri Lou Pendergrass, M.D., Ph.D.

Original Release Date: July 1, 2021  Expiration Date: July 1, 2024

TOPIC 1: Prevention of Type 2 Diabetes/Treatment of Obesity.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Recognize patients with pre-diabetes.
  2. Employ current Guidelines and recommendations regarding diabetes prevention.
  3. Describe properties of currently available medications for obesity, their adverse effect profile, and how to incorporate them as part of an effective obesity treatment program.

TOPIC 2: Treatment of Hyperglycemia in Type 2 Diabetes (Non-Insulin)

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Understand the glucose targets in T2DM.
  2. Employ the current ADA Guidelines for pharmacological therapy.
  3. Develop individualized therapeutic regimens to optimize glycemic control.

TOPIC 3: Treatment of Hyperglycemia in Type 2 Diabetes (Insulin)

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Recognize indications for the initiation of insulin replacement therapy for people with T2DM.
  2. Describe clinically relevant properties of the available insulins and insulin combinations.
  3. Individualize and advance insulin therapy to optimize glycemic control.